Accumulating evidence indicates that chemicals found in myriad settings and materials can exert a significant impact on the endocrine system.

The chronic health condition affects more than your pancreas.

Diabetes patients and provider need to remain vigilant with glucose testing and insulin dosing post jab.

Cortisol gets a bad rap, but it's not so clear-cut.

Poor inpatient glycemic management is associated with increased lengths of stay and in-hospital morbidity and mortality.

Nearly 38 million people in the U.S. are living with diabetes, yet treating patients without stigma-centric language is not part of it, according to Mihail Zilbermint, MD, a physician at Johns Hopkins in Baltimore.

To overcome the potential looming dearth in the next generation of endocrinologists, Suburban Hospital in Bethesda, Md., is using a unique interactive method to inspire and engage young minds.

At-home medical testing, ranging from cancer screening to COVID-19 detection, may be transforming health care, but some direct-to-consumer hormone test kits have raised red flags for endocrinologists.

Umair Ansari, PharmD, BCPS, BCCCP, Suburban Hospital, co-authored an article on the physiological impact of Ramadan on diabetes.

Mihail Zilbermint, M.D., participated in the development of the new composite metric for the quality of glycemia from continuous glucose monitor tracings and co-authored the article on the subject.

Many signs and symptoms of a hormonal imbalance are associated with other health issues. Here's what to look out for and when to see a doctor.

We know that having diabetes increases the risk of severe COVID symptoms — but now, research points to the reverse also being true.

Although he's an adult endocrinologist, volunteering at an overnight summer camp for children living with type 1 diabetes has made Mihail Zilbermint, M.D., a better doctor.

With insulin becoming unaffordable to many diabetics in the US, how has this community fared during a pandemic, unemployment, and loss of employer-sponsored health care?

Endocrine News gets a firsthand look at a community hospital’s use of an IDMS from both endocrinologists and a patient who experienced the service after a diabetes diagnosis.

We know that having diabetes is a risk factor for more serious COVID-19 disease, but is being seriously ill from COVID-19 a risk factor for diabetes?

Researchers don’t understand exactly how the disease might trigger Type 1 or Type 2 diabetes, or whether the cases are temporary or permanent.

Mihail Zilbermint, M.D., is an unusual medical provider in an atypical practice setting: he's a full-time endocrine hospitalist who heads an inpatient diabetes management service at a small community hospital.

Mihail Zilbermint, M.D., discusses how the COVID-19 virus has changed the way he practices medicine in a hospital setting, and how his approach to treating patients may be changed forever. Photo Courtesy of Endocrine News.

Initiatives targeting hypoglycemia and insulin pen wastage could lead to dramatic cost savings in small community hospitals, new data suggest.